<DOC>
	<DOC>NCT00113308</DOC>
	<brief_summary>This study is being conducted to find out if an investigational drug called GW406381 can help people with rheumatoid arthritis.</brief_summary>
	<brief_title>COX-2 Inhibitor Study In Patients With Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis, Rheumatoid</mesh_term>
	<mesh_term>Cyclooxygenase 2 Inhibitors</mesh_term>
	<criteria>Inclusion criteria: Rheumatoid arthritis (RA) for at least 12 months. Required a nonsteroidal antiinflammatory drug (NSAID) or COX2 inhibitor for RA for at least 5 out of 7 days of each week for the 4 weeks prior to screening. Exclusion criteria: Any history of cardiovascular disease (e.g., heart attack, stroke, congestive heart failure, uncontrolled high blood pressure), documented peripheral arterial insufficiency and symptomatic, clinically significant claudication, or who have a history of peripheral arterial embolism. Have an active stomach ulcer or history of any stomach tear or bleeding.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Rheumatoid Arthritis</keyword>
	<keyword>COX-2 Inhibitor</keyword>
</DOC>